Global reach Greiner Bio-One Americas is part of a 28-location, 22-country network with a diverse portfolio spanning Preanalytics and BioScience. This indicates opportunities to cross-sell integrated lab solutions, software, and storage systems to multinational customers and institutions with standardized needs.

Integrated solutions The company offers a full stack from collection systems and eHealth software to cell culture products, biobanking storage, and high-throughput microplates. Target buyers include hospitals, labs, universities, and biotech firms seeking end-to-end preanalytical to analytical workflows.

Innovation track Recent product launches such as EVOPROTECT and VACUETTE lines, plus investments in 3D cell culture tech, point to a strong product pipeline. This presents sales opportunities around upgraded safety, efficiency, and automation features for existing customers and trial pilots with new prospects.

Strategic partnerships Recent partnerships and acquisitions, including Science Logistics collaboration and SKS365 Malta acquisition, suggest a readiness to expand distribution reach and service capabilities. Leverage these moves to position Greiner Bio-One as a reliable supplier for logistics-intensive, regulated environments.

Mid-market focus With revenue in the 50–100 million range and a workforce of 201–500, Greiner Bio-One Americas targets mid-market labs and institutions that value quality, safety, and standardization. Sales plays can emphasize value-led procurement, lifecycle support, and scalable solutions for growing research programs.